NASDAQ: ICPT
Intercept Pharmaceuticals Inc Stock

$15.38-0.23 (-1.47%)
Updated Jan 25, 2022
ICPT Price
$15.38
Fair Value Price
$17.53
Market Cap
$454.43M
52 Week Low
$11.60
52 Week High
$38.43
P/E
-4.75x
P/B
-2.91x
P/S
1.33x
PEG
N/A
Dividend Yield
N/A
Revenue
$354.33M
Earnings
-$107.29M
Gross Margin
99.2%
Operating Margin
-15.79%
Profit Margin
-30.3%
Debt to Equity
-4.35
Operating Cash Flow
-$61M
Beta
1.31
Next Earnings
Feb 23, 2022
Ex-Dividend
N/A
Next Dividend
N/A

ICPT Overview

Zen Score

High
Medium
Low
Industry Average (23)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how ICPT scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

ICPT ($15.38) is undervalued by 12.28% relative to our estimate of its Fair Value price of $17.53 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Valuation
ICPT's cash and short-term investments ($428.77M) can cover ICPT's cash burn for the next year ($63.77M), even accounting for increasing cash burn (91.22%)
Financials
ICPT's profit margin has increased... subscribe to Premium to read more.
Financials
There are 16 more ICPT due diligence checks available for Premium users.

ICPT News

Valuation

ICPT fair value

Fair Value of ICPT stock based on Discounted Cash Flow (DCF)
Price
$15.38
Fair Value
$17.53
Undervalued by
12.28%
ICPT ($15.38) is undervalued by... subscribe to Premium to read more.
Valuation

ICPT price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-4.75x
Industry
21x
Market
33.66x

ICPT price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
-2.91x
Industry
4.53x

ICPT's financial health

Profit margin

Revenue
$92.8M
Net Income
-$3.6M
Profit Margin
-3.9%
ICPT's cash and short-term investments... subscribe to Premium to read more.
Financials
ICPT's profit margin has increased... subscribe to Premium to read more.
Financials

Assets to liabilities

Assets
$523.1M
Liabilities
$679.1M
Debt to equity
-4.35
ICPT's short-term assets ($496.34M) exceed... subscribe to Premium to read more.
Financials
ICPT's long-term liabilities ($535.25M) exceed... subscribe to Premium to read more.
Financials
ICPT's debt relative to shareholder... subscribe to Premium to read more.
Financials
ICPT's debt to equity ratio... subscribe to Premium to read more.
Financials

Cash flow

Operating
$4.6M
Investing
-$84.3M
Financing
$3.4M
ICPT's cash and short-term investments... subscribe to Premium to read more.
Financials

Intercept Pharmaceuticals Stock FAQ

What is Intercept Pharmaceuticals's quote symbol?

(NASDAQ: ICPT) Intercept Pharmaceuticals trades on the NASDAQ under the ticker symbol ICPT. Intercept Pharmaceuticals stock quotes can also be displayed as NASDAQ: ICPT.

What is the 52 week high and low for Intercept Pharmaceuticals (NASDAQ: ICPT)?

(NASDAQ: ICPT) Intercept Pharmaceuticals's 52-week high was $38.43, and its 52-week low was $11.60. It is currently -59.98% from its 52-week high and 32.59% from its 52-week low.

How much is Intercept Pharmaceuticals stock worth today?

(NASDAQ: ICPT) Intercept Pharmaceuticals currently has 29,546,974 outstanding shares. With Intercept Pharmaceuticals stock trading at $15.38 per share, the total value of Intercept Pharmaceuticals stock (market capitalization) is $454.43M.

Intercept Pharmaceuticals stock was originally listed at a price of $19.40 in Oct 11, 2012. If you had invested in Intercept Pharmaceuticals stock at $19.40, your return over the last 9 years would have been -20.72%, for an annualized return of -2.55% (not including any dividends or dividend reinvestments).

How much is Intercept Pharmaceuticals's stock price per share?

(NASDAQ: ICPT) Intercept Pharmaceuticals stock price per share is $15.38 today (as of Jan 25, 2022).

What is Intercept Pharmaceuticals's Market Cap?

(NASDAQ: ICPT) Intercept Pharmaceuticals's market cap is $454.43M, as of Jan 26, 2022.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Intercept Pharmaceuticals's market cap is calculated by multiplying ICPT's current stock price of $15.38 by ICPT's total outstanding shares of 29,546,974.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.